Investigating intrinsic 138La radioactivity of LaBr3:Ce scintillation crystals using dual-mode HPGe spectrometry and GEANT4 simulations
Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment · 2027-02 · 1094 · 172157
DOI: 10.1016/j.nima.2026.172157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 2027-02. Verfasst von Soni Devi und 5 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Indian Institute of Technology Ropar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Indian Institute of Technology Ropar
Zitieren
APA
Devi, S., Khanduri, S., Kaur, S., Goswami, R., Priyanka, & Singh, P. P. (2027). Investigating intrinsic 138La radioactivity of LaBr3:Ce scintillation crystals using dual-mode HPGe spectrometry and GEANT4 simulations. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 1094, 172157. https://doi.org/10.1016/j.nima.2026.172157
Vancouver
Devi S, Khanduri S, Kaur S, Goswami R, Priyanka, Singh PP. Investigating intrinsic 138La radioactivity of LaBr3:Ce scintillation crystals using dual-mode HPGe spectrometry and GEANT4 simulations. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 2027;1094:172157. doi:10.1016/j.nima.2026.172157
BibTeX
@article{Devi2027,
author = {Devi, Soni and Khanduri, Shreya and Kaur, Sarabjot and Goswami, Rabina and Priyanka and Singh, Pushpendra P.},
title = {Investigating intrinsic 138La radioactivity of LaBr3:Ce scintillation crystals using dual-mode HPGe spectrometry and GEANT4 simulations},
journal = {Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment},
year = {2027},
volume = {1094},
pages = {172157},
doi = {10.1016/j.nima.2026.172157}
}
EUVIMED